Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits

[1]  Brett R. Wenner,et al.  Metabolomics Applied to Diabetes Research , 2009, Diabetes.

[2]  Huiru Tang,et al.  Human serum metabonomic analysis reveals progression axes for glucose intolerance and insulin resistance statuses. , 2009, Journal of proteome research.

[3]  Shuang Cai,et al.  Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride. , 2009, Journal of pharmaceutical and biomedical analysis.

[4]  A. Smilde,et al.  Metabolic Profiling of the Response to an Oral Glucose Tolerance Test Detects Subtle Metabolic Changes , 2009, PloS one.

[5]  W. Cefalu.  Inflammation, Insulin Resistance, and Type 2 Diabetes: Back to the Future? , 2009, Diabetes.

[6]  E. Schleicher,et al.  Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at? , 2009, American journal of physiology. Endocrinology and metabolism.

[7]  John T. Wei,et al.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression , 2009, Nature.

[8]  C. Barbas,et al.  Correlative and quantitative 1H NMR-based metabolomics reveals specific metabolic pathway disturbances in diabetic rats. , 2008, Analytical biochemistry.

[9]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[10]  J. Lindon,et al.  Systems biology: Metabonomics , 2008, Nature.

[11]  J. Chen,et al.  Effect of a traditional Chinese medicine preparation Xindi soft capsule on rat model of acute blood stasis: a urinary metabonomics study based on liquid chromatography-mass spectrometry. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  H. Vogel,et al.  Metabolomic profiling of dietary‐induced insulin resistance in the high fat–fed C57BL/6J mouse , 2008, Diabetes, obesity & metabolism.

[13]  Christian Baumgartner,et al.  Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. , 2008, The Journal of clinical investigation.

[14]  Kay S Tatsuoka,et al.  Multi-platform investigation of the metabolome in a leptin receptor defective murine model of type 2 diabetes. , 2008, Molecular bioSystems.

[15]  Ian D. Wilson,et al.  Metabolic Phenotyping in Health and Disease , 2008, Cell.

[16]  Peiyuan Yin,et al.  Serum metabolic profiling of abnormal savda by liquid chromatography/mass spectrometry. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  Ru Wei,et al.  Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity , 2008, Molecular systems biology.

[18]  Johan Auwerx,et al.  Targeting bile-acid signalling for metabolic diseases , 2008, Nature Reviews Drug Discovery.

[19]  E. Schleicher,et al.  Induction of stearoyl-CoA desaturase protects human arterial endothelial cells against lipotoxicity. , 2008, American journal of physiology. Endocrinology and metabolism.

[20]  F. Mach,et al.  Insulin Resistance: A Proinflammatory State Mediated by Lipid-Induced Signaling Dysfunction and Involved in Atherosclerotic Plaque Instability , 2008, Mediators of inflammation.

[21]  Ian J. Brown,et al.  Human metabolic phenotype diversity and its association with diet and blood pressure , 2008, Nature.

[22]  F. Schick,et al.  Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans , 2008, Diabetologia.

[23]  K. Kaski,et al.  1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death , 2008, Molecular systems biology.

[24]  Haifeng Lu,et al.  Symbiotic gut microbes modulate human metabolic phenotypes , 2008, Proceedings of the National Academy of Sciences.

[25]  W. Matson,et al.  Metabolomic profiling to develop blood biomarkers for Parkinson's disease. , 2008, Brain : a journal of neurology.

[26]  Jeremy K. Nicholson,et al.  Gut microbiota: a potential new territory for drug targeting , 2008, Nature Reviews Drug Discovery.

[27]  Xin Lu,et al.  Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information. , 2008, Analytical chemistry.

[28]  D. Eizirik,et al.  The role for endoplasmic reticulum stress in diabetes mellitus. , 2008, Endocrine reviews.

[29]  E. Cummins,et al.  The clinical effectiveness and cost-effectiveness of inhaled insulin in diabetes mellitus: a systematic review and economic evaluation. , 2007, Health technology assessment.

[30]  J. K. Nicholson,et al.  Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice , 2007, Diabetologia.

[31]  F. Schick,et al.  Lifestyle intervention in individuals with normal versus impaired glucose tolerance , 2007, European journal of clinical investigation.

[32]  P Zimmet,et al.  International Diabetes Federation: a consensus on Type 2 diabetes prevention , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[33]  J. van der Greef,et al.  Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers. , 2007, British journal of clinical pharmacology.

[34]  R. Cox,et al.  A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. , 2007, Physiological genomics.

[35]  Oliver Fiehn,et al.  A comprehensive urinary metabolomic approach for identifying kidney cancerr. , 2007, Analytical biochemistry.

[36]  I. Wilson,et al.  Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. , 2007, Journal of proteome research.

[37]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[38]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[39]  Xianlin Han,et al.  Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death Published, JLR Papers in Press, September 7, 2006. , 2006, Journal of Lipid Research.

[40]  I. Wilson,et al.  The detection of phenotypic differences in the metabolic plasma profile of three strains of Zucker rats at 20 weeks of age using ultra-performance liquid chromatography/orthogonal acceleration time-of-flight mass spectrometry. , 2006, Rapid communications in mass spectrometry : RCM.

[41]  R. DeFronzo,et al.  Insulin Secretion and Action in Subjects With Impaired Fasting Glucose and Impaired Glucose Tolerance , 2006, Diabetes.

[42]  I. Wilson,et al.  A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats. , 2006, Molecular bioSystems.

[43]  M. Rantalainen,et al.  The comparative metabonomics of age-related changes in the urinary composition of male Wistar-derived and Zucker (fa/fa) obese rats. , 2006, Molecular bioSystems.

[44]  John D Sorkin,et al.  The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. , 2005, Diabetes care.

[45]  M. Alberiche,et al.  Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study. , 2005, Diabetes care.

[46]  Ping Li,et al.  Peroxisome Proliferator-activated Receptor-γ Co-activator 1α-mediated Metabolic Remodeling of Skeletal Myocytes Mimics Exercise Training and Reverses Lipid-induced Mitochondrial Inefficiency* , 2005, Journal of Biological Chemistry.

[47]  Jianren Gu,et al.  Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. , 2005, Analytical chemistry.

[48]  I. Wilson,et al.  Gut microorganisms, mammalian metabolism and personalized health care , 2005, Nature Reviews Microbiology.

[49]  Darren K Mcguire,et al.  Impaired glucose tolerance and impaired fasting glucose — a review of diagnosis, clinical implications and management , 2005, Diabetes & vascular disease research.

[50]  N. Stefan,et al.  Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells. , 2004, Diabetes.

[51]  I. Wilson,et al.  Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects. , 2004, Journal of pharmaceutical and biomedical analysis.

[52]  J. van der Greef,et al.  The role of analytical sciences in medical systems biology. , 2004, Current opinion in chemical biology.

[53]  E. Schleicher,et al.  Palmitate, but Not Unsaturated Fatty Acids, Induces the Expression of Interleukin-6 in Human Myotubes through Proteasome-dependent Activation of Nuclear Factor-κB* , 2004, Journal of Biological Chemistry.

[54]  A. Karter,et al.  Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. , 2004, Diabetes.

[55]  Anthony F. P. Nash,et al.  A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. , 2003, Journal of pharmaceutical and biomedical analysis.

[56]  J. Nicholson,et al.  Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics , 2002, Nature Medicine.

[57]  J. Shaw,et al.  Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[58]  M. Stumvoll,et al.  Suppression of systemic, intramuscular, and subcutaneous adipose tissue lipolysis by insulin in humans. , 2000, The Journal of clinical endocrinology and metabolism.

[59]  H. Brunengraber,et al.  Glutamate, a window on liver intermediary metabolism. , 2000, The Journal of nutrition.

[60]  S. Wold,et al.  Orthogonal signal correction of near-infrared spectra , 1998 .

[61]  Y. T. Chen,et al.  Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood. , 1993, American journal of human genetics.

[62]  John M. Walker,et al.  Metabolic Profiling , 2011, Methods in Molecular Biology.

[63]  U. Edlund,et al.  Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. , 2008, Analytical chemistry.

[64]  J. Leahy.  Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for care , 2008 .

[65]  Olga Ilkayeva,et al.  Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. , 2008, Cell metabolism.

[66]  A. Brennan,et al.  Screening for type 2 diabetes: literature review and economic modelling. , 2007, Health technology assessment.

[67]  R. DeFronzo,et al.  Insulin Secretion and Action in Subjects With Impaired Fasting Glucose and Impaired Glucose Tolerance Results From the Veterans Administration Genetic Epidemiology Study , 2006 .

[68]  G. Rutten,et al.  Screening for Type 2 Diabetes , 2003 .

[69]  J. Lindon,et al.  So what's the deal with metabonomics? , 2003, Analytical chemistry.

[70]  Edda Klipp,et al.  Systems Biology , 1994 .